Clinical Response of Levodopa Carbidopa Combination in Patients with Idiopathic Parkinsonism
Introduction: Parkinson’s disease is the most common form of a group of progressive neurodegenerative disorders. The use of levodopa as dopamine – replacement therapy is highly effective in ameliorating the symptoms of the disease and remains the standard drug with which other therapies are comp...
Main Authors: | ABHIJITH LALESH MERAJOTH, PRADEEP SADASIVAN PILLAI, THOMAS IYPE |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2016-05-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/7886/16043_CE(Ra1)_F(GH)_PF1(ROAK)_PFA(AK)_PF2(PAG).pdf |
Similar Items
-
Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease
by: Hauser RA, et al.
Published: (2018-03-01) -
Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale
by: Priya Jagota, et al.
Published: (2022-05-01) -
Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients
by: Thomas Müller, et al.
Published: (2022-04-01) -
Relation between oral diadochokinesis and disease severity in Iranian patients with idiopathic Parkinson`s disease
by: F. Majdinasab, et al.
Published: (2011-09-01) -
Predicting Depression in Parkinson’s Disease Using Commonly Available PD Questionnaires
by: Emanuele Camerucci, et al.
Published: (2024-04-01)